Panduratin A from Boesenbergia rotunda suppresses hepatitis B virus by targeting HNF1α and synergizing with antiviral agents
Authors:
- Piyanoot ThongsriPTPiyanoot Thongsri
- Yongyut PewkliangYPYongyut Pewkliang
- Suparerk BorwornpinyoSBSuparerk Borwornpinyo
- Adisak WongkajornsilpAWAdisak Wongkajornsilp
- Pakatip RuenraroengsakPRPakatip Ruenraroengsak
- Usanarat AnurathapanUAUsanarat Anurathapan
- Abhasnee SobhonslidsukASAbhasnee Sobhonslidsuk
- Suradej HongengSHSuradej Hongeng
- Khanit Sa-NgiamsuntornKSKhanit Sa-Ngiamsuntorn
Open Access
- 7 January 2026
- journal article
- research article
- Published by Springer Nature in Chinese Medicine
- Vol. 21 (1) , 10
Abstract
Background: Boesenbergia rotunda (fingerroot) is widely used in traditional medicine, and its bioactive compound panduratin A has demonstrated potent antiviral properties. However, the mechanistic basis underlying its anti-hepatitis B virus (HBV) activity remains to be fully elucidated. Methods: HBV-infected human hepatocytes (imHCs) were treated with B. rotunda extract, panduratin A, or pinostrobin. Intracellular HBV DNA, secreted HBsAg and HBeAg, and pregenomic RNA (pgRNA) were quantified in dose- and time-dependent experiments. Luciferase reporter assays were used to assess HBV promoter activity. The roles of HNF1α and HNF4α were evaluated by siRNA-mediated knockdown and ectopic gene expression. Drug interaction studies were performed using the KDM5 inhibitor GS-5801 and the capsid assembly modulator NVR-3778. A 3D liver spheroid model was used to validate antiviral effects on HBV DNA and cccDNA. Gene interaction network analysis was conducted to identify central regulatory pathways. Results: B. rotunda extract, panduratin A, and pinostrobin significantly suppressed intracellular HBV DNA, HBsAg, HBeAg, and pgRNA. Panduratin A exhibited the strongest antiviral activity and inhibited preS1, preS2, and core promoter activities. Panduratin A markedly downregulated HNF1α expression, with only modest effects on HNF4α. Knockdown of HNF1α significantly reduced the antiviral efficacy of panduratin A, whereas ectopic HNF1α expression rescued its inhibitory effects. Co-treatment with GS-5801 produced synergistic activity, and combination with NVR-3778 yielded additive antiviral effects. In 3D liver spheroids, panduratin A reduced intracellular HBV DNA and cccDNA with minimal cytotoxicity. Network analysis further identified HNF1α as a key regulatory node modulated by panduratin A. Conclusion: Panduratin A is a potent anti-HBV compound that acts primarily through HNF1α-dependent suppression of HBV transcription and replication. Its efficacy in combination therapy and in 3D liver models highlights its potential as a promising candidate for future HBV treatment strategies. GraphicalKeywords
Funding Information
- Mahidol University
- Mahidol University
This publication has 72 references indexed in Scilit:
- Comparative Study between the 3D‐Liver Spheroid Models Developed from HepG2 and Immortalized Hepatocyte‐Like Cells with Primary Hepatic Stellate Coculture for Drug Metabolism Analysis and Anticancer Drug ScreeningAdvanced Therapeutics, 2022
- FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4αAntiviral Research, 2019
- Saikosaponin C exerts anti-HBV effects by attenuating HNF1α and HNF4α expression to suppress HBV pgRNA synthesisInflammation Research, 2019
- 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and ApplicationsBiotechnology Journal, 2019
- Immunological cure of HBV infectionHepatology International, 2019
- Hepatitis B vaccine nonrespondersAnnals of Allergy, Asthma & Immunology, 2018
- Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spreadHepatology International, 2017
- AASLD guidelines for treatment of chronic hepatitis BHepatology, 2015
- Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysisHepatology, 2015
- Anticancer properties of panduratin A isolated from Boesenbergia pandurata (Zingiberaceae)Journal of Natural Medicines, 2006